Zhi-Hong Zong

Zhi-Hong Zong


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
YXYin-Ling Xiu
Yin-Ling Xiu
KSKai-Xuan Sun
Kai-Xuan Sun
XCXi Chen
Xi Chen
SCShuo Chen
Shuo Chen
YZYang Zhao
Yang Zhao
ZZZhi-Hong Zong
Zhi-Hong Zong
Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3 Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3

4 February 2015 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
XCXi Chen
Xi Chen
SCShuo Chen
Shuo Chen
YXYin-Ling Xiu
Yin-Ling Xiu
KSKaixuan SUN
Kaixuan SUN
ZZZhi-Hong Zong
Zhi-Hong Zong
YZYang Zhao
Yang Zhao
An increasing amount of evidence has revealed that microRNAs regulate various biological processes, including cell differentiation, cell proliferation, apoptosis, drug resistance, and fat metabolism. Studies have shown that miR-93’s targetome in cancer has not been fully defined. Moreover, the role of miR-93 in epithelial ovarian carcinoma (EOC) remains largely unknown. MIR-93 mRNA expression in normal ovarian tissue, benign tumors, borderline tumors, primary ovarian carcinomas, and metastatic omentum was quantified. The ovarian carcinoma cell lines OVCAR3, SKOV3/DDP, and HO8910-PM were transfected with miR-93-5P, after which cell phenotype and expression of relevant molecules were assayed. Dual-luciferase reporter assay and a xenograft mouse model were used to examine miR-93 and its target gene RHOC (Ras homolog gene family member C). MIR-93 mRNA expression was significantly lower in ovarian carcinomas and borderline tumors than in normal ovarian tissues (p < 0.05), and was lower in metastatic omentum than in relative primary ovarian carcinomas (p < 0.05). MIR-93 mRNA expression was also negatively associated with differentiation (well vs. poor and moderate) and International Federation of Gynecology and Obstetrics staging (FIGO stage I/II vs. stage III/IV) in ovarian carcinoma (p < 0.05), besides, miR-93 was higher expressed in mucinous adenocarcinoma than the other types (p < 0.05). MiR-93-5P overexpression reduced proliferation (p < 0.05); promoted G1 or S arrest and apoptosis (p < 0.05); suppressed migration and invasion (p < 0.05); and reduced RhoC, P70S6 kinase, Bcl-xL, matrix metalloproteinase 9 (MMP9) mRNA or protein expression; conversely, it induced P53 and cleaved PARP expression (p < 0.05). Dual-luciferase reporter assay indicated that miR-93 directly targeted RhoC by binding its 3′ untranslated region. MiR-93-5P transfection also suppressed tumor development and RhoC expression (determined by immunohistochemistry) in vivo in the xenograft mouse model (p < 0.05). This is the first demonstration that miR-93-5P may inhibit EOC tumorigenesis and progression by targeting RhoC. These findings indicate that miR-93-5P is a potential suppressor of ovarian cellular proliferation. The involvement of miR-93-5P–mediated RhoC downregulation in inhibiting EOC aggressiveness may provide extended insight into the molecular mechanisms underlying cancer aggressiveness.

13 February 2016 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
JYJing Yan
Jing Yan
JJJing-Yi Jiang
Jing-Yi Jiang
XMXiao-Na Meng
Xiao-Na Meng
YXYin-Ling Xiu
Yin-Ling Xiu
ZZZhi-Hong Zong
Zhi-Hong Zong
It has been proposed that cyclin G1 (CCNG1) participates in p53-dependent G1–S and G2 checkpoints and might function as an oncogenic protein in the initiation and metastasis of ovarian carcinoma. MicroRNA 23b (miR-23b) is a critical regulatory factor in the progression of many cancer cell types that targets the relevant genes. MiR-23b expression in ovarian tissues was quantified by quantitative reverse transcription–PCR. The ovarian cancer cell lines OVCAR3, HO8910-PM, and SKOV3/DDP were transfected with miR-23b, after we assayed the cell phenotype and expression of the relevant molecules. Dual-luciferase reporter assay and a xenograft mouse model were used to examine the expression of miR-23b and its target gene CCNG1. MIR23B mRNA expression was significantly lower in epithelial ovarian carcinoma and borderline tumors than in normal ovarian tissues and benign tumors, and miR-23b expression among ages and pathological subtypes was significantly different. CCNG1 mRNA expression was significantly lower in normal ovarian tissues than in benign tumors, borderline tumors, and ovarian carcinomas, and expression among pathological subtypes was significantly different. MiR-23b overexpression inhibited ovarian cancer cell proliferation, invasion, and migration, and induced apoptosis. Dual-luciferase reporter assay showed that miR-23b bound with the 3′ untranslated region of CCNG1. MiR-23b overexpression significantly downregulated CCNG1, urokinase, survivin, Bcl-xL, P70S6K, and matrix metallopeptidase-9 (MMP9) mRNA and protein expression. Furthermore, miR-23b inhibited tumor growth and suppressed CCNG1 expression in vitro. Our findings show that miR-23b may inhibit ovarian cancer tumorigenesis and progression by downregulating CCNG1 and the expression of the relevant genes. MiR-23b is a potentially novel application for regulating ovarian carcinoma progression.

5 February 2016 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
DWDi-Di Wu
Di-Di Wu
XLXue-Song Li
Xue-Song Li
XMXiao-Na Meng
Xiao-Na Meng
JYJing Yan
Jing Yan
ZZZhi-Hong Zong
Zhi-Hong Zong

1 February 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
XGXue Guan
Xue Guan
SCShuo Chen
Shuo Chen
YLYao Liu
Yao Liu
LWLi-Li Wang
Li-Li Wang
YZYang Zhao
Yang Zhao
ZZZhi-Hong Zong
Zhi-Hong Zong

1 June 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
FSFan Shen
Fan Shen
ZZZhi-Hong Zong
Zhi-Hong Zong
YLYao Liu
Yao Liu
SCShuo Chen
Shuo Chen
XSXiujie Sheng
Xiujie Sheng
YZYang Zhao
Yang Zhao
CEMIP is a cell migration-inducing protein that is closely associated with carcinogenesis. However, the function of CEMIP has not been reported in ovarian cancer. Here we show that CEMIP expression level in ovarian cancer tissues was higher than that in normal ovaries. Silencing of CEMIP in ovarian cancer cell lines A2780 and OVCAR3 significantly decreased cell proliferation, cell migration and invasion capacity, while the proportion of apoptotic cells was increased. In addition, Western blotting demonstrated that knockdown of CEMIP inhibited activation of the PI3K/AKT signaling pathway. Altogether, these data suggest that CEMIP may promote the development of ovarian cancer by regulating PI3K/AKT signaling.